HRP20020226B1 - Signal sequences for the production of leu-hirudine via secretion by e. coli in a culture medium - Google Patents
Signal sequences for the production of leu-hirudine via secretion by e. coli in a culture mediumInfo
- Publication number
- HRP20020226B1 HRP20020226B1 HR20020226A HRP20020226A HRP20020226B1 HR P20020226 B1 HRP20020226 B1 HR P20020226B1 HR 20020226 A HR20020226 A HR 20020226A HR P20020226 A HRP20020226 A HR P20020226A HR P20020226 B1 HRP20020226 B1 HR P20020226B1
- Authority
- HR
- Croatia
- Prior art keywords
- leu
- signal sequences
- hirudine
- coli
- production
- Prior art date
Links
- 108010076504 Protein Sorting Signals Proteins 0.000 title abstract 3
- 241000588724 Escherichia coli Species 0.000 title 1
- 239000001963 growth medium Substances 0.000 title 1
- 230000028327 secretion Effects 0.000 title 1
- 102000007625 Hirudins Human genes 0.000 abstract 1
- 108010007267 Hirudins Proteins 0.000 abstract 1
- 241000589540 Pseudomonas fluorescens Species 0.000 abstract 1
- 241000607715 Serratia marcescens Species 0.000 abstract 1
- 241000863432 Shewanella putrefaciens Species 0.000 abstract 1
- 102000019259 Succinate Dehydrogenase Human genes 0.000 abstract 1
- 108010012901 Succinate Dehydrogenase Proteins 0.000 abstract 1
- WQPDUTSPKFMPDP-OUMQNGNKSA-N hirudin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(OS(O)(=O)=O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2)=O)CSSC1)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)CSSC1)C(C)C)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 WQPDUTSPKFMPDP-OUMQNGNKSA-N 0.000 abstract 1
- 229940006607 hirudin Drugs 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Gastroenterology & Hepatology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19944870A DE19944870A1 (de) | 1999-09-18 | 1999-09-18 | Signalsequenzen zur Herstellung von Leu-Hirudin über Sekretion durch E. coli in das Kulturmedium |
| PCT/EP2000/008537 WO2001021662A1 (de) | 1999-09-18 | 2000-09-01 | Signalsequenzen zur herstellung von leu-hirudin über sekretion durch e. coli in das kulturmedium |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HRP20020226A2 HRP20020226A2 (en) | 2004-04-30 |
| HRP20020226B1 true HRP20020226B1 (en) | 2010-08-31 |
Family
ID=7922547
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20020226A HRP20020226B1 (en) | 1999-09-18 | 2002-03-15 | Signal sequences for the production of leu-hirudine via secretion by e. coli in a culture medium |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US7455987B1 (pl) |
| EP (1) | EP1216259B1 (pl) |
| JP (1) | JP4669181B2 (pl) |
| KR (1) | KR100737189B1 (pl) |
| CN (2) | CN1269838C (pl) |
| AR (1) | AR025660A1 (pl) |
| AT (1) | ATE357458T1 (pl) |
| AU (1) | AU775923B2 (pl) |
| BR (1) | BR0014519A (pl) |
| CA (1) | CA2385287C (pl) |
| CZ (1) | CZ2002899A3 (pl) |
| DE (2) | DE19944870A1 (pl) |
| DK (1) | DK1216259T3 (pl) |
| EE (1) | EE05187B1 (pl) |
| HK (2) | HK1049172A1 (pl) |
| HR (1) | HRP20020226B1 (pl) |
| HU (1) | HUP0202596A3 (pl) |
| IL (2) | IL148624A0 (pl) |
| ME (1) | MEP27908A (pl) |
| MX (1) | MXPA02002469A (pl) |
| NO (1) | NO329723B1 (pl) |
| NZ (1) | NZ517825A (pl) |
| PL (1) | PL205117B1 (pl) |
| RS (1) | RS50435B (pl) |
| RU (1) | RU2261867C2 (pl) |
| SK (1) | SK287865B6 (pl) |
| TR (2) | TR200501541T2 (pl) |
| WO (1) | WO2001021662A1 (pl) |
| ZA (1) | ZA200202106B (pl) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7638618B2 (en) | 2001-02-20 | 2009-12-29 | Sanofi-Aventis Deutschland Gmbh | Nucleic acids encoding a hirudin and pro-insulin as superscretable peptides and for parallel improvement of the exported forms of one or more polypeptides of interest |
| US7202059B2 (en) | 2001-02-20 | 2007-04-10 | Sanofi-Aventis Deutschland Gmbh | Fusion proteins capable of being secreted into a fermentation medium |
| US9453251B2 (en) | 2002-10-08 | 2016-09-27 | Pfenex Inc. | Expression of mammalian proteins in Pseudomonas fluorescens |
| WO2005089093A2 (en) * | 2003-11-21 | 2005-09-29 | Dow Global Technologies Inc. | Improved expression systems with sec-system secretion |
| EP2412816B1 (en) | 2004-07-26 | 2014-12-03 | Pfenex Inc. | Process for improved protein expression by strain engineering |
| DE102005046113A1 (de) * | 2005-09-27 | 2007-03-29 | Sanofi-Aventis Deutschland Gmbh | Verfahren zur Amidierung von Polypetiden mit C-terminalen basischen Aminosäuren unter Verwendung spezifischer Endoproteasen |
| DE102006044841A1 (de) | 2006-09-22 | 2008-04-03 | Wacker Chemie Ag | Signalpeptid zur Produktion von rekombinanten Proteinen |
| BRPI0807834A2 (pt) | 2007-01-31 | 2014-07-22 | Dow Global Technologies Inc | " sequências-líder bacterianas para expressão aumentada ". |
| MX2009011523A (es) | 2007-04-27 | 2009-11-09 | Dow Global Technologies Inc | Metodo para clasificar rapidamente huespedes microbianos para identificar ciertas cepas con rendimiento y/o calidad mejorados en la expresion de proteinas heterologas. |
| US9580719B2 (en) | 2007-04-27 | 2017-02-28 | Pfenex, Inc. | Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins |
| ES2853935T3 (es) | 2013-03-12 | 2021-09-20 | Massachusetts Gen Hospital | Proteínas modificadas de sustancia inhibidora muleriana (MIS) y usos de las mismas para el tratamiento de enfermedades |
| CA3151082A1 (en) | 2013-12-11 | 2015-06-18 | The General Hospital Corporation | Use of mullerian inhibiting substance (mis) proteins for contraception and ovarian reserve preservation |
| CN108220369B (zh) * | 2017-12-04 | 2021-03-12 | 广东双骏生物科技有限公司 | 一种生产重组水蛭素的方法 |
| CN108359689B (zh) * | 2018-01-19 | 2021-03-23 | 华中农业大学 | 利用抗病基因识别无毒效应蛋白以鉴定具有分泌功能信号肽的方法 |
| CN115572329B (zh) * | 2021-06-21 | 2024-02-06 | 王大勇 | 一组活性增强代谢较慢的菲牛蛭基因重组水蛭素及其制备方法 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0448093A2 (de) * | 1990-03-22 | 1991-09-25 | Consortium für elektrochemische Industrie GmbH | Sekretion von Hirudinderivaten |
| US5389529A (en) * | 1991-06-12 | 1995-02-14 | Regeneron Pharmaceuticals, Inc. | Modified lamβ signal sequence and processes for producing recombinant neurotrophins |
| US5652139A (en) * | 1987-04-23 | 1997-07-29 | Monsanto Company | DNA comprising lamb secretion signal sequence and mature IGF-1 sequence |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3429430A1 (de) * | 1984-08-10 | 1986-02-20 | Hoechst Ag, 6230 Frankfurt | Gentechnologisches verfahren zur herstellung von hirudin und mittel zur durchfuehrung dieses verfahrens |
| EP0324712B1 (de) * | 1985-04-11 | 1993-04-07 | Hoechst Aktiengesellschaft | Hirudin-Derivat |
| AU604925B2 (en) * | 1988-02-23 | 1991-01-03 | Schering Aktiengesellschaft | A hirudin derivative |
| JPH07119237B2 (ja) * | 1990-11-08 | 1995-12-20 | 株式会社ジャパンエナジー | ヒルジン変異体，その製造法及び抗凝血剤 |
| ATE140929T1 (de) * | 1990-11-08 | 1996-08-15 | Japan Energy Corp | Hirudinmutante, deren herstellung, antikoagulans, sekretorischer vektor, durch besagten vektor transformierter mikroorganismus und herstellung eines produkts durch besagten mikroorganismus |
| NZ243084A (en) * | 1991-06-12 | 1995-08-28 | Regeneron Pharma | Production and recovery of recombinant neurotrophins, genes for a modified lamb signal sequence, fusion genes and plasmids |
| DE4140381A1 (de) | 1991-12-07 | 1993-06-09 | Hoechst Ag, 6230 Frankfurt, De | Neue synthetische isohirudine mit verbesserter stabilitaet |
-
1999
- 1999-09-18 DE DE19944870A patent/DE19944870A1/de not_active Withdrawn
-
2000
- 2000-09-01 JP JP2001525235A patent/JP4669181B2/ja not_active Expired - Fee Related
- 2000-09-01 IL IL14862400A patent/IL148624A0/xx unknown
- 2000-09-01 TR TR2005/01541T patent/TR200501541T2/xx unknown
- 2000-09-01 AU AU68421/00A patent/AU775923B2/en not_active Ceased
- 2000-09-01 CA CA2385287A patent/CA2385287C/en not_active Expired - Fee Related
- 2000-09-01 AT AT00956507T patent/ATE357458T1/de not_active IP Right Cessation
- 2000-09-01 RU RU2002110278/13A patent/RU2261867C2/ru not_active IP Right Cessation
- 2000-09-01 CN CNB2004100346716A patent/CN1269838C/zh not_active Expired - Fee Related
- 2000-09-01 DE DE50014189T patent/DE50014189D1/de not_active Expired - Lifetime
- 2000-09-01 NZ NZ517825A patent/NZ517825A/en not_active IP Right Cessation
- 2000-09-01 DK DK00956507T patent/DK1216259T3/da active
- 2000-09-01 RS YUP-146/02A patent/RS50435B/sr unknown
- 2000-09-01 MX MXPA02002469A patent/MXPA02002469A/es active IP Right Grant
- 2000-09-01 WO PCT/EP2000/008537 patent/WO2001021662A1/de active IP Right Grant
- 2000-09-01 ME MEP-279/08A patent/MEP27908A/xx unknown
- 2000-09-01 KR KR1020027003577A patent/KR100737189B1/ko not_active IP Right Cessation
- 2000-09-01 PL PL354444A patent/PL205117B1/pl not_active IP Right Cessation
- 2000-09-01 EE EEP200200139A patent/EE05187B1/xx not_active IP Right Cessation
- 2000-09-01 EP EP00956507A patent/EP1216259B1/de not_active Expired - Lifetime
- 2000-09-01 CN CNB00812955XA patent/CN1192037C/zh not_active Expired - Fee Related
- 2000-09-01 HU HU0202596A patent/HUP0202596A3/hu unknown
- 2000-09-01 CZ CZ2002899A patent/CZ2002899A3/cs unknown
- 2000-09-01 TR TR2002/00667T patent/TR200200667T2/xx unknown
- 2000-09-01 BR BR0014519-0A patent/BR0014519A/pt not_active Application Discontinuation
- 2000-09-01 SK SK362-2002A patent/SK287865B6/sk not_active IP Right Cessation
- 2000-09-14 AR ARP000104820A patent/AR025660A1/es active IP Right Grant
- 2000-09-18 US US09/664,326 patent/US7455987B1/en not_active Expired - Lifetime
-
2002
- 2002-03-11 IL IL148624A patent/IL148624A/en not_active IP Right Cessation
- 2002-03-13 NO NO20021254A patent/NO329723B1/no not_active IP Right Cessation
- 2002-03-14 ZA ZA200202106A patent/ZA200202106B/en unknown
- 2002-03-15 HR HR20020226A patent/HRP20020226B1/xx not_active IP Right Cessation
-
2003
- 2003-02-18 HK HK03101205A patent/HK1049172A1/xx not_active IP Right Cessation
-
2005
- 2005-01-13 HK HK05100336A patent/HK1068352A1/xx not_active IP Right Cessation
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5652139A (en) * | 1987-04-23 | 1997-07-29 | Monsanto Company | DNA comprising lamb secretion signal sequence and mature IGF-1 sequence |
| EP0448093A2 (de) * | 1990-03-22 | 1991-09-25 | Consortium für elektrochemische Industrie GmbH | Sekretion von Hirudinderivaten |
| US5389529A (en) * | 1991-06-12 | 1995-02-14 | Regeneron Pharmaceuticals, Inc. | Modified lamβ signal sequence and processes for producing recombinant neurotrophins |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20020226B1 (en) | Signal sequences for the production of leu-hirudine via secretion by e. coli in a culture medium | |
| FR15C0055I2 (fr) | Feuillets de l'epithelium corneen humain reconstitues in vitro et methode de production de ces derniers | |
| DK0833839T3 (da) | Heterocykliske peptidylforbindelser, der er nyttige til behandling af thrombinrelaterede sygdomme | |
| BR0112676A (pt) | Bifenilcarboxamidas | |
| DK0399666T3 (da) | Fusionsproteiner indeholdende N-terminalfragmenter af human serumalbumin | |
| ATE121625T1 (de) | Pharmazeutische zusammensetzung. | |
| AU2002243205A1 (en) | Enhanced secretion of a polypeptide by a microorganism | |
| ATE326454T1 (de) | Neue bernsteinsäure derivative als cysteine- protease-inhibitoren | |
| MX9803897A (es) | Enzimas con puntos isoelectricos bajos para usarse en limpieza de lentes de contacto. | |
| NO20033161L (no) | Linsepleieprodukt inneholdende dexpantenol | |
| DE50111331D1 (de) | Neue verwendung von proteinhydrolysaten | |
| DE69708591D1 (de) | Schlüsselzwischenprodukte zur Herstellung von Simvastatin | |
| IT1269578B (it) | Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo acido, una ciclodestrina e una base. | |
| AU4255996A (en) | New dipeptide p-amidinobenzylamides with n-terminal sulfonyl or aminosulfonyl radicals | |
| WO2002030958A3 (de) | Casein-peptidfragmente mit wachstumsbeeinflussender aktivität auf zellkulturen | |
| IS6654A (is) | Stöðugt gabapentín með pH innan stýrðra marka | |
| ATE427320T1 (de) | Behandlung von infektionen verursacht von mikroorganismen | |
| EA200400624A1 (ru) | Нетоксичные для нервной ткани плазминоген-активирующие факторы для лечения инсульта | |
| DE59610251D1 (de) | Konjugat, umfassend einen wirkstoff, ein polypeptid und einen polyether | |
| ES2142490T3 (es) | Ciclopeptolidos. | |
| ES2185628T3 (es) | Procedimiento para preparar proteinas modificadas. | |
| FR2798140B1 (fr) | Hydrolysats enzymatiques d'huitres et leurs applications | |
| FR2819809B1 (fr) | Peptides presentant un affinite pour la proteine virale gp120, et utilisation de ces peptides | |
| BR0108409A (pt) | Derivados de aminoácidos e sua utilização como inibidores da nep, da ace e da ece | |
| DE69229545D1 (de) | Neuartige proteasen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1OB | Publication of a patent application | ||
| ARAI | Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application | ||
| PNAN | Change of the applicant name, address/residence |
Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH, DE |
|
| B1PR | Patent granted | ||
| ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20110829 Year of fee payment: 12 |
|
| PBON | Lapse due to non-payment of renewal fee |
Effective date: 20120902 |